Similar articles for PMID: 15910557

Year	Number of Results
1967	1
1985	1
1986	2
1987	3
1989	4
1990	1
1993	2
1995	4
1996	3
1997	8
1998	3
1999	5
2000	6
2001	12
2002	11
2003	17
2004	25
2005	25
2006	16
2007	25
2008	24
2009	17
2010	18
2011	22
2012	23
2013	24
2014	18
2015	12
2016	3
2017	5
2018	6
2019	5
2020	5
2021	5
2022	2
2024	0

1

Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

Wolffenbuttel BH, Franken AA, Vincent HH; Dutch Corall Study Group. Wolffenbuttel BH, et al. J Intern Med. 2005 Jun;257(6):531-9. doi: 10.1111/j.1365-2796.2005.01499.x. J Intern Med. 2005. PMID: 15910557 Free article. Clinical Trial.

2

Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

Strandberg TE, Feely J, Sigurdsson EL; DISCOVERY study group. Strandberg TE, et al. Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015. Clin Ther. 2004. PMID: 15639694 Clinical Trial.

3

Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study).

Milionis HJ, Rizos E, Kostapanos M, Filippatos TD, Gazi IF, Ganotakis ES, Goudevenos J, Mikhailidis DP, Elisaf MS. Milionis HJ, et al. Curr Med Res Opin. 2006 Jun;22(6):1123-31. doi: 10.1185/030079906X112462. Curr Med Res Opin. 2006. PMID: 16846545 Clinical Trial.

4

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.

Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M. Schwartz GG, et al. Am Heart J. 2004 Jul;148(1):e4. doi: 10.1016/j.ahj.2004.01.020. Am Heart J. 2004. PMID: 15215813 Clinical Trial.

5

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Jones PH, et al. Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006. Clin Ther. 2004. PMID: 15531001 Clinical Trial.

6

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.

Betteridge DJ, Gibson JM. Betteridge DJ, et al. Diabet Med. 2007 May;24(5):541-9. doi: 10.1111/j.1464-5491.2007.02095.x. Epub 2007 Mar 15. Diabet Med. 2007. PMID: 17367312 Clinical Trial.

7

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Sasaki J, et al. Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017. Clin Ther. 2008. PMID: 18640465 Clinical Trial.

8

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

Stender S, Schuster H, Barter P, Watkins C, Kallend D; MERCURY I Study Group. Stender S, et al. Diabetes Obes Metab. 2005 Jul;7(4):430-8. doi: 10.1111/j.1463-1326.2004.00450.x. Diabetes Obes Metab. 2005. PMID: 15955130

9

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M; DISCOVERY PENTA investigators. Fonseca FA, et al. Curr Med Res Opin. 2005 Aug;21(8):1307-15. doi: 10.1185/030079905X56529. Curr Med Res Opin. 2005. PMID: 16083541 Clinical Trial.

10

LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.

Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH. Jukema JW, et al. Curr Med Res Opin. 2005 Nov;21(11):1865-74. doi: 10.1185/030079905X74952. Curr Med Res Opin. 2005. PMID: 16307708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

332 results

Results by year